Several new medications are revolutionizing blood sugar care, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide being highlighted potential candidates. Retatrutide, a dual GIP and GLP-1 receptor stimulant, demonstrates substantial weight loss along with better glucose regulation. Cagr